Cardiometabolic Health Congress | Agenda | CME Conference Schedule, Symposia, Keynote Session, Presentations

Home

•

Site Map

•

Useful Links

Join Us On

October 2-5, 2013 · Sheraton Hotel · Boston, MA

Cardiometabolic Health Congress: CME conference on hypertension, dyslipidemia, obesity, cardiovascular risk, atherosclerosis, kidney disease, metabolic syndrome, cardiovascular disease, cardiometabolic risk, educational meeting

Join Our Mailing List

2012 Congress Details

2011 Congress Details

2010 Congress Details

2009 Congress Details

2008 Congress Details

2007 Congress Details

2006 Congress Details

2012 Online CME Activity

Useful Links

Recommend This Site

Download
2013 CMHC Brochure

2012 Program Agenda

Wednesday Thursday Friday Saturday

Join our mailing list to receive the latest updates.
Note: Agenda & Faculty are subject to change.

Wednesday, October 10, 2012
12:45pm – 2:15pm	Afternoon Symposium PAH Management 2012: Expert Analysis of Landmark Trials, Long-Term Outcomes & Implications for Clinical Practice Supported by an educational grant from Actelion Pharmaceuticals US, Inc.	Harrison Farber, MD Myung Park, MD Lewis Rubin, MD
2:30pm – 3:45pm	Symposium (non-CME) Fixed-Dose Triple Combination Therapy for Patients with Uncontrolled Hypertension on Dual Combination Therapy Sponsored by Daiichi Sankyo, Inc.	Robert Busch, MD
4:00pm – 5:15pm	Symposium (non-CME) Vascepa: A New Therapy for the Treatment of Severe Hypertriglyceridemia Sponsored by Amarin Pharma Inc.	Harold Bays, MD
6:30pm – 8:30pm	Dinner Symposium A Personalized T2DM Management: Maximizing the Role of GLP-1 RA Therapy in the Continuum of Care Supported by an educational grant from Amylin Pharmaceuticals, Inc.	Richard Bergenstal, MD Robert Chilton, DO Anne Peters, MD Carol Wysham, MD
6:30pm –8:00pm	Dinner Symposium B (non-CME) New Treatment Options for Obesity Sponsored by VIVUS, Inc.	Donna Ryan, MD

Thursday, October 11, 2012
6:15am – 7:45am	Breakfast Symposium A Intensive Glycemic Control & CV Risk Reduction: The Impact of Early Insulin Therapy on Macrovascular Outcomes in Patients with Dysglycemia Supported by an educational grant from Sanofi-aventis U.S. Inc., A SANOFI COMPANY	Richard Bergenstal, MD Vivian Fonseca, MD Jorge Plutzky, MD Matthew Riddle, MD
6:15am – 7:45am	Breakfast Symposium B Obesity Management 2012: Novel Targeting of the CNS for Weight Loss, Glycemic Control & Cardiovascular Risk Reduction Supported by an educational grant from Eisai Inc.	Caroline Apovian, MD Harold Bays, MD Robert Eckel, MD Robert Kushner, MD
8:00am – 8:05am	Opening Remarks	Jay Skyler, MD
8:05am – 9:15am	Keynote Session Cardiometabolic Health 2012: Guideline Updates & Implications for Clinical Practice	Moderator: Robert Eckel, MD Presenters: Silvio Inzucchi, MD Suzanne Oparil, MD Neil Stone, MD
9:15am – 9:45am	Prevention of CVD in Patients with Diabetes	James Gavin III, MD
9:45am – 10:15am	Glycemic Control During and After CCU/ Inpatient Setting	Irl Hirsch, MD
10:15am – 11:15am	Morning Break/Exhibit Hall
11:15am – 12:00pm	T2DM 2012: Expert Recommendations & Evidence-Based Strategies for Achieving Optimal Results: Panel Discussion & Audience Q&A	Moderator: Jay Skyler, MD Panelists: James Gavin III, MD Irl Hirsch, MD Silvio Inzucchi, MD
12:15pm – 1:45pm	Lunch Symposium A Basal Insulin 2012: A New Generation of Strategies to Optimize Glucose Control Supported by an educational grant from Novo Nordisk, Inc.	Timothy Bailey, MD Irl Hirsch, MD Luigi Meneghini, MD Bernard Zinman, MD
12:15pm – 1:45pm	Lunch Symposium B Statin Therapy 2012: Selecting the Right Pathway to Optimize Outcomes for Clinically Complex Patients Supported by an educational grant from Kowa Pharmaceuticals America, Inc. and Lilly USA, LLC	Christie Ballantyne, MD Michael Davidson, MD JoAnne Foody, MD Peter Toth, MD
2:00pm – 2:45pm	Keynote Session Are We Ready for Bariatric Surgery as the Treatment of Choice for T2DM?	Francesco Rubino, MD
2:45pm – 3:15pm	Expanding Evidence that Obesity Can Be Successfully Managed by Behavioral Interventions	Lawrence Appel, MD
3:15pm – 4:15pm	Afternoon Break/Exhibit Hall
4:15pm – 4:45pm	The Mechanistic and Therapeutic Link Between Obesity and Diabetes: Where Are We & Where Do We Need to Go?	Allison Goldfine, MD
4:45pm – 5:30pm	Integrating Evidence-Based Strategies into Clinical Practice for the Management of Patients with Obesity & T2DM	Moderator: Robert Eckel, MD Panelists: Lawrence Appel, MD James Gavin III, MD Allison Goldfine, MD Irl Hirsch, MD Silvio Inzucchi, MD Francesco Rubino, MD
5:30pm	Closing Remarks	Robert Eckel, MD
5:45pm - 6:45pm	Welcome Reception
7:00pm – 9:00pm	Dinner Symposium GLP-1 Agonist Therapy 2012: Cutting-Edge Data and Clinical Implications for the Spectrum of Patients with T2DM Supported by an educational grant from Novo Nordisk, Inc.	Vivian Fonseca, MD Richard Pratley, MD Julio Rosenstock, MD Bernard Zinman, MD

Friday, October 12, 2012
6:15am – 7:45am	Breakfast Symposium A A Closer Look at Severe and Familial Hypercholesterolemia: Expert Analysis of Pathophysiology and the Role of ApoB Inhibition Supported by an educational grant from Genzyme, A SANOFI COMPANY	Sergio Fazio, MD Allan Sniderman, MD Sotirios Tsimikas, MD James A. Underberg, MD
6:15am – 7:45am	Breakfast Symposium B Glycemic Control & CV Outcomes in Perspective: Expert Analysis of Clinical Trials Evaluating Oral & Incretin-Based Therapies Supported by an educational grant from Bristol-Myers Squibb and AstraZeneca LP	Deepak L. Bhatt, MD, MPH Jaime Davidson, MD Jorge Plutzky, MD Benjamin Scirica, MD
8:05am – 8:10am	Opening Remarks	Christie Ballantyne, MD
8:10am – 9:30am	Keynote Session Inflammation & Cardiometabolic Risk: Translating the Science into Clinical Practice	Moderator: Christie Ballantyne, MD Presenters: Peter Libby, MD Paul Ridker, MD
9:30am – 10:30am	Morning Break/Exhibit Hall
10:30am – 11:45am	Late-Breaking Clinical Trials & FDA Update: How Will the Latest Data Impact Clinical Practice?	Moderator: Robert Eckel, MD Panelists: Christie Ballantyne, MD Keith Ferdinand, MD Jay Skyler, MD Stephen Wiviott, MD
12:00pm – 1:30pm	Lunch Symposium A Expert Analysis of Innovative Antiplatelet Data: Clinical Implications for Patients with ACS Undergoing PCI Supported by an educational grant from Daiichi Sankyo, Inc. and Eli Lilly and Company	Michelle O'Donoghue, MD Marc Sabatine, MD Gregg Stone, MD Stephen Wiviott, MD
12:00pm – 1:30pm	Lunch Symposium B Advances in Weight-Loss Management: Examining the Clinical Impact of Novel Therapies on Obesity, Diabetes & Cardiometabolic Risk Supported by an educational grant from VIVUS, Inc.	Robert Eckel, MD W. Timothy Garvey, MD Lee M. Kaplan, MD Jorge Plutzky, MD Arya Sharma, MD
1:45pm – 3:15pm	Clinical Controversies in Lipid Management: Viewpoints of Guidelines & Case-Based Discussion	Moderator: Christie Ballantyne, MD Panelists: Harold Bays, MD Robert Eckel, MD JoAnne Foody, MD
3:15pm – 4:15pm	Afternoon Break/Exhibit Hall
4:15pm – 5:30pm	Evaluation and Management of Kidney Function in Patients with CAD	Moderator: George Bakris, MD Presenters: Ron Blankstein, MD Peter McCullough, MD
5:30pm	Closing Remarks	George Bakris, MD
6:00pm – 8:00pm	Dinner Symposium State-of-the-Art Management of Mixed Dyslipidemia & Residual CV Risk: Expert Analysis on the Emerging Role of Omega-3 Fatty Acids Supported by an educational grant from Amarin Pharma Inc.	Harold Bays, MD Deepak L. Bhatt, MD, MPH William Cromwell, MD Terry Jacobson, MD Ernst Schaefer, MD

Saturday, October 13, 2012
6:15am – 7:45am	Breakfast Symposium Expert Perspectives on Endothelial Function, HTN, and CV Risk: Cutting-Edge Data on the Impact of Novel Beta Blockers Along the HTN Continuum of Care Supported by an educational grant from Forest Laboratories, Inc.	George Bakris, MD Keith Ferdinand, MD Thomas Giles, MD Addison Taylor, MD
8:05am – 8:10am	Opening Remarks	Christie Ballantyne, MD
8:10am – 9:15am	Hot Topics in Thrombosis & ACS	Moderator: Deepak L. Bhatt, MD, MPH Panelists: Peter Berger, MD Matthew Roe, MD
9:15am – 9:45am	Comparative Approach to Achieving BP Goals: How Many Ways to Interpret the Data?	George Bakris, MD
9:45am – 10:00am	Morning Break
10:00am – 12:00pm	Clinical Dilemmas & Evidence-Based Solutions for HTN Management: Roundtable Case-based Discussion & Audience Q&A	Moderator: George Bakris, MD Presenters: Domenic Sica, MD Alan Weder, MD William White, MD
12:00pm	Closing Remarks	George Bakris, MD